Medicine

Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells

F. Cianci, I. Verduci, R. Cazzoli, G. Cannavale, G. Rey, Marina Veronesi, B. Balboni, M. Ranucci, L. Palloni, Federico Ballabio, N. Barsotti, Giorgia Ailuno, Alice Balboni, S. Baldassari, G. Caviglioli, C. Tacconi, C. Camilloni, S. Girotto, Alessandro Fantin, Federica Barbieri, A. Cavalli, M. Pasqualetti, T. Florio, S. Minucci, Michele Mazzanti

2026.1.20JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

DOI: 10.1186/s13046-025-03628-9

Abstract

Abstract is not available.

Citation format

CIANCI, F., et al. Correction: Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmclic1 membrane protein in glioblastoma-initiating cells. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2026, 45(1): 18.